Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives

References

• Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosisAm J Med19939466466508506892
   PubMed Web of Science ®Google Scholar
• O’NeillTWFelsenbergDVarlowJCooperCKanisJASilmanAJThe prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis StudyJ Bone Miner Res1996117101010188797123
   PubMed Web of Science ®Google Scholar
• LookerACOrwollESJohnstonCCJrPrevalence of low femoral bone density in older U.S. adults from NHANES IIIJ Bone Miner Res19971211176117689383679
   PubMed Web of Science ®Google Scholar
• KanisJAJohnellOOdenAJonssonBDe LaetCDawsonARisk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosisBone200027558559011062343
   PubMed Web of Science ®Google Scholar
• Ministry of Civil Affairs released 2013 Social Services Development Statistics Bulletin [webpage on the Internet]Ministry of Civil Affairs of the People’s Republic of China Available from http://www.mca.gov.cn/article/zwgk/mzyw/201406/20140600654488.shtmlAccessed May 21, 2015
   Google Scholar
• GuilleminFMartinezLCalvertMFear of falling, fracture history, and comorbidities are associated with health-related quality of life among European and US women with osteoporosis in a large international studyOsteoporos Int201324123001301023754200
   PubMed Web of Science ®Google Scholar
• HarveyNCMatthewsPCollinsRCooperCUK Biobank Musculoskeletal Advisory GroupOsteoporosis epidemiology in UK Biobank: a unique opportunity for international researchersOsteoporos Int201324122903290524057481
   PubMed Web of Science ®Google Scholar
• FontenotHBHarrisALPharmacologic management of osteoporosisJ Obstet Gynecol Neonatal Nurs2014432236245
   Web of Science ®Google Scholar
• LevineJPPharmacologic and nonpharmacologic management of osteoporosisClin Cornerstone200681405317591575
   PubMedGoogle Scholar
• Assessment of fracture risk and its application to screening for postmenopausal osteoporosis Report of a WHO Study GroupWorld Health Organ Tech Rep Ser199484311297941614
   PubMed Web of Science ®Google Scholar
• KungAWFanTXuLFactors influencing diagnosis and treatment of osteoporosis after a fragility fracture among postmenopausal women in Asian countries: a retrospective studyBMC Womens Health201313723410131
   PubMed Web of Science ®Google Scholar
• KanisJADelmasPBurckhardtPCooperCTorgersonDGuidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone DiseaseOsteoporos Int1997743904069373575
   PubMed Web of Science ®Google Scholar
• KanisJAGlüerCCAn update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis FoundationOsteoporos Int200011319220210824234
   PubMed Web of Science ®Google Scholar
• KanisJAMeltonLJ3rdChristiansenCJohnstonCCKhaltaevNThe diagnosis of osteoporosisJ Bone Miner Res199498113711417976495
   PubMed Web of Science ®Google Scholar
• YangYWangBFeiQValidation of an osteoporosis self-assessment tool to identify primary osteoporosis and new osteoporotic vertebral fractures in postmenopausal Chinese women in BeijingBMC Musculoskelet Disord20131427124053509
   PubMed Web of Science ®Google Scholar
• Geohive [homepage on the Internet]Global Population Statistics Available from www.geohive.comAccessed 21 May, 2015
   Google Scholar
• National Bureau of Statistics of the People’s Republic of China [homepage on the Internet]China Statistical Yearbook Available from http://www.stats.gov.cn/tjsj/ndsj/Accessed 21 May, 2015
   Google Scholar
• XuanQingyunInterpretation for the “White paper of Osteoporosis prevention in China” in the twelfth orthopaedic academic conference of Chinese Medical Association and the fifth COA International Academic Conference2010ChengduSichuan province of ChinaChinese
   Google Scholar
• LiuZHZhaoYLDingGZZhouYEpidemiology of primary osteoporosis in ChinaOsteoporos Int19977Suppl 3S84S879536309
   PubMed Web of Science ®Google Scholar
• LiNOuPZhuHYangDZhengPPrevalence rate of osteoporosis in the mid – aged and elderly in selected parts of ChinaChin Med J (Engl)2002115577377512133555
   PubMed Web of Science ®Google Scholar
• ZhangZShenXZhangHThe relationship between body composition and fracture risk using the FRAX model in central south Chinese postmenopausal womenClin Endocrinol (Oxf)201277452453022469329
   PubMed Web of Science ®Google Scholar
• LöfmanOBerglundKLarssonLTossGChanges in hip fracture epidemiology: redistribution between ages, genders and fracture typesOsteoporos Int2002131182511878451
   PubMed Web of Science ®Google Scholar
• WangJWangYLiuWDWangFYinZSHip fractures in Hefei, China: the Hefei osteoporosis projectJ Bone Miner Metab201432220621423784553
   PubMed Web of Science ®Google Scholar
• DhanwalDKCooperCDennisonEMGeographic variation in osteoporotic hip fracture incidence: the growing importance of Asian influences in coming decadesJ Osteoporos2010201075710220981334
   PubMedGoogle Scholar
• El MaghraouiANgbandaARBensaoudNBensaoudMRezqiATaziMAAge-adjusted incidence rates of hip fractures between 2006 and 2009 in Rabat, MoroccoOsteoporos Int20132441267127322736070
   PubMed Web of Science ®Google Scholar
• DohenyMOSedlakCAEstokPJZellerROsteoporosis knowledge, health beliefs, and DXA T-scores in men and women 50 years of age and olderOrthop Nurs200726424325017882102
   PubMed Web of Science ®Google Scholar
• JubyAGDavisPA prospective evaluation of the awareness, knowledge, risk factors and current treatment of osteoporosis in a cohort of elderly subjectsOsteoporos Int200112861762211580074
   PubMed Web of Science ®Google Scholar
• WongCPLokMKWunYTPangSMChinese men’s knowledge and risk factors of osteoporosis: compared with women’sAm J Mens Health20148215916624027205
   PubMed Web of Science ®Google Scholar
• LeeLYLaiEKOsteoporosis in older Chinese men: knowledge and health beliefsJ Clin Nurs200615335335516466485
   PubMed Web of Science ®Google Scholar
• CenterJRNguyenTVSchneiderDSambrookPNEismanJAMortality after all major types of osteoporotic fracture in men and women: an observational studyLancet1999353915687888210093980
   PubMed Web of Science ®Google Scholar
• BliucDNguyenNDMilchVENguyenTVEismanJACenterJRMortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and womenJAMA2009301551352119190316
   PubMed Web of Science ®Google Scholar
• WuXPHouYLZhangHEstablishment of BMD reference databases for the diagnosis and evaluation of osteoporosis in central southern Chinese menJ Bone Miner Metab200826658659418979158
   PubMed Web of Science ®Google Scholar
• DonaldsonMGCawthonPMLuiLYOsteoporotic Fractures in Men (MrOS) Study GroupEstimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US National Osteoporosis Foundation guidelinesJ Bone Miner Res20102571506151120200971
   PubMed Web of Science ®Google Scholar
• GourlayMLFineJPPreisserJSStudy of Osteoporotic Fractures Research GroupBone-density testing interval and transition to osteoporosis in older womenN Engl J Med2012366322523322256806
   PubMed Web of Science ®Google Scholar
• GuoPWangSZhuYPrevalence of osteopenia and osteoporosis and factors associated with decreased bone mineral density in elderly inpatients with psychiatric disorders in Huzhou, ChinaShanghai Arch Psychiatry201224526227025328349
   PubMedGoogle Scholar
• MeltonLJ3rdThamerMRayNFFractures attributable to osteoporosis: report from the National Osteoporosis FoundationJ Bone Miner Res199712116239240721
   PubMed Web of Science ®Google Scholar
• JohnellOKanisJAAn estimate of the worldwide prevalence and disability associated with osteoporotic fracturesOsteoporos Int200617121726173316983459
   PubMed Web of Science ®Google Scholar
• China Medical Association of Osteoporosis and Bone Mineral ResearchGuidelines for diagnosis and treatment of primary osteoporsis (2011)Chinese Journal of Osteoporosis and Bone Mineral Research201141217 Chinese
   Google Scholar
• LiuJMMaLYBiYFA population-based study examining cal-caneus quantitative ultrasound and its optimal cut-points to discriminate osteoporotic fractures among 9352 Chinese women and menJ Clin Endocrinol Metab201297380080922170722
   PubMed Web of Science ®Google Scholar
• HuoDLiLA case – control study on risk factors for hip fracture in the middle – aged and elderly in BeijingZhonghua Liu Xing Bing Xue Za Zhi20002113740 Chinese11860756
   PubMedGoogle Scholar
• JiangBQZhongPHChengXBYangXLYangJCaoYFInvestigation of health and nutrition status of middle-aged and old residents in the urban district of ChongqingAsia Pac J Clin Nutr200716Suppl 1172117392070
   PubMed Web of Science ®Google Scholar
• CheungEYHoAYLamKFTamSKungAWDeterminants of bone mineral density in Chinese menOsteoporos Int200516121481148616133639
   PubMed Web of Science ®Google Scholar
• LauEMLeungPCKwokTThe determinants of bone mineral density in Chinese men – results from Mr Os (Hong Kong), the first cohort study on osteoporosis in Asian menOsteoporos Int200617229730316175311
   PubMed Web of Science ®Google Scholar
• MarshallDJohnellOWedelHMeta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fracturesBMJ19963127041125412598634613
   PubMed Web of Science ®Google Scholar
• StoneKLSeeleyDGLuiLYOsteoporotic Fractures Research GroupBMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic FracturesJ Bone Miner Res200318111947195414606506
   PubMed Web of Science ®Google Scholar
• KanisJAJohnellOOdenAJohanssonHMcCloskeyEFRAX and the assessment of fracture probability in men and women from the UKOsteoporos Int200819438539718292978
   PubMed Web of Science ®Google Scholar
• TsangSWKungAWKanisJAJohanssonHOdenATen-year fracture probability in Hong Kong Southern Chinese according to age and BMD femoral neck T-scoresOsteoporos Int200920111939194519326036
   PubMed Web of Science ®Google Scholar
• ZhangZOuYShengZLiaoEHow to decide intervention thresholds based on FRAX in central south Chinese postmenopausal womenEndocrine201445219519724146412
   PubMed Web of Science ®Google Scholar
• PeifangWThe cost statistic of osteoporotic fracture treatment from 2000 to 2004Chinese Journal of Osteoporosis200603274277 Chinese
   Google Scholar
• LuoLZXuLStudy on direct economic-burden and its risk factors of osteoporotic hip fractureZhonghua Liu Xing Bing Xue Za Zhi2005269669672 Chinese16471214
   PubMedGoogle Scholar
• QuBMaYYanMThe economic burden of fracture patients with osteoporosis in western ChinaOsteoporos Int20142571853186024691649
   PubMed Web of Science ®Google Scholar
• GullbergBJohnellOKanisJAWorld-wide projections for hip fractureOsteoporos Int1997754074139425497
   PubMed Web of Science ®Google Scholar
• CooperCColeZAHolroydCRIOF CSA Working Group on Fracture EpidemiologySecular trends in the incidence of hip and other osteoporotic fracturesOsteoporos Int20112251277128821461721
   PubMed Web of Science ®Google Scholar
• CummingsSRXuLChenXZhaoXYuWGeQBone mass, rates of osteoporotic fractures, and prevention of fractures: are there differences between China and Western countries?Chin Med Sci J1994931972007865845
   PubMedGoogle Scholar
• XuLLuAZhaoXChenXCummingsSRVery low rates of hip fracture in Beijing, People’s Republic of China the Beijing Osteoporosis ProjectAm J Epidemiol199614499019078890668
   PubMed Web of Science ®Google Scholar
• YanLZhouBPrenticeAWangXGoldenMHEpidemiological study of hip fracture in Shenyang, People’s Republic of ChinaBone19992421511559951786
   PubMed Web of Science ®Google Scholar
• ZhangLChengABaiZEpidemiology of cervical and trochant-eric fractures of the proximal femur in 1994 in Tangshan, ChinaJ Bone Miner Metab2000182848810701163
   PubMed Web of Science ®Google Scholar
• TianFMZhangLZhaoHYLiangCYZhangNSongHPAn increase in the incidence of hip fractures in Tangshan, ChinaOsteoporos Int20142541321132524562838
   PubMed Web of Science ®Google Scholar
• XiaWBHeSLXuLRapidly increasing rates of hip fracture in Beijing, ChinaJ Bone Miner Res201227112512921956596
   PubMed Web of Science ®Google Scholar
• WangCBLinCFLiangWMExcess mortality after hip fracture among the elderly in Taiwan: a nationwide population-based cohort studyBone201356114715323727435
   PubMed Web of Science ®Google Scholar
• HahnBHOsteoporosis: diagnosis and managementBull Rheum Dis1988382193071392
   PubMedGoogle Scholar
• ChauPHWongMLeeALingMWooJTrends in hip fracture incidence and mortality in Chinese population from Hong Kong 2001–2009Age Ageing201342222923323204430
   PubMed Web of Science ®Google Scholar
• BrauerCACoca-PerraillonMCutlerDMRosenABIncidence and mortality of hip fractures in the United StatesJAMA2009302141573157919826027
   PubMed Web of Science ®Google Scholar
• HaentjensPAutierPBaretteMVenkenKVanderschuerenDBoonenSHip Fracture Study GroupSurvival and functional outcome according to hip fracture type: a one-year prospective cohort study in elderly women with an intertrochanteric or femoral neck fractureBone200741695896417913614
   PubMed Web of Science ®Google Scholar
• ShyuYIChenMCLiangJLuJFWuCCSuJYChanges in quality of life among elderly patients with hip fracture in TaiwanOsteoporos Int20041529510214605800
   PubMed Web of Science ®Google Scholar
• StrömOBorgstromFZethraeusNLong-term cost and effect on quality of life of osteoporosis-related fractures in SwedenActa Orthop200879226928018484255
   PubMed Web of Science ®Google Scholar
• EkmanEFThe role of the orthopaedic surgeon in minimizing mortality and morbidity associated with fragility fracturesJ Am Acad Orthop Surg201018527828520435878
   PubMed Web of Science ®Google Scholar
• JiangHXMajumdarSRDickDADevelopment and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fracturesJ Bone Miner Res200520349450015746995
   PubMed Web of Science ®Google Scholar
• BaudoinCFardellonePBeanKOstertag-EzembeAHervyFClinical outcomes and mortality after hip fracture: a 2-year follow-up studyBone1996183 Suppl149S157S8777081
   PubMed Web of Science ®Google Scholar
• CummingsSRMeltonLJEpidemiology and outcomes of osteoporotic fracturesLancet200235993191761176712049882
   PubMed Web of Science ®Google Scholar
• SuzukiNOgikuboOHanssonTThe course of the acute vertebral body fragility fracture: its effect on pain, disability and quality of life during 12 monthsEur Spine J200817101380139018751742
   PubMed Web of Science ®Google Scholar
• KungAWEpidemiology and diagnostic approaches to vertebral fractures in AsiaJ Bone Miner Metab200422317017515108057
   PubMed Web of Science ®Google Scholar
• SuzukiNOgikuboOHanssonTThe prognosis for pain, disability, activities of daily living and quality of life after an acute osteo-porotic vertebral body fracture: its relation to fracture level, type of fracture and grade of fracture deformationEur Spine J2009181778819082846
   PubMed Web of Science ®Google Scholar
• GraziottiPJGraziottiCRSangsterAMSignificance of preoperative MRI in establishing levels of augmentation for percutaneous vertebro-plastyJ Pain Res2013635936523690700
   PubMed Web of Science ®Google Scholar
• LingXCummingsSRMingweiQVertebral fractures in Bei-jing, China: the Beijing Osteoporosis ProjectJ Bone Miner Res200015102019202511028456
   PubMed Web of Science ®Google Scholar
• KwokAWGongJSWangYXPrevalence and risk factors of radiographic vertebral fractures in elderly Chinese men and women: results of Mr OS (Hong Kong) and Ms OS (Hong Kong) studiesOsteoporos Int201324387788522707064
   PubMed Web of Science ®Google Scholar
• TsaiKTwuSChiengPYangRLeeTPrevalence of vertebral fractures in Chinese men and women in urban Taiwanese communitiesCalcif Tissue Int19965942492538781047
   PubMed Web of Science ®Google Scholar
• TsangSWBowCHChuEYYeungSCSoongCCKungAWClinical risk factor assessment had better discriminative ability than bone mineral density in identifying subjects with vertebral fractureOsteoporos Int201122266767420503038
   PubMed Web of Science ®Google Scholar
• IpICheungSKCheungTCOSHK Task Group for Formulation of 2013 OSHK Guideline for Clinical Management of Postmenopausal Osteoporosis in Hong KongOsteoporosis Society of Hong KongThe Osteoporosis Society of Hong Kong (OSHK): 2013 OSHK guideline for clinical management of postmenopausal osteoporosis in Hong KongHong Kong Med J201319Suppl 214023535738
   PubMed Web of Science ®Google Scholar
• TruumeesEOsteoporosisSpine (Phila Pa 1976)200126893093211317115
   PubMed Web of Science ®Google Scholar
• BorgströmFZethraeusNJohnellOCosts and quality of life associated with osteoporosis-related fractures in SwedenOsteoporos Int200617563765016283064
   PubMed Web of Science ®Google Scholar
• LindsayRSilvermanSLCooperCRisk of new vertebral fracture in the year following a fractureJAMA2001285332032311176842
   PubMed Web of Science ®Google Scholar
• HasseriusRKarlssonMKNilssonBERedlund-JohnellIJohnellOEuropean Vertebral Osteoporosis StudyPrevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis StudyOsteoporos Int2003141616812577186
   PubMed Web of Science ®Google Scholar
• CooperCMeltonLJ3rdEpidemiology of osteoporosisTrends Endocrinol Metab19923622422918407104
   PubMed Web of Science ®Google Scholar
• DiasJJAn analysis of the nature of injury in fractures of the neck of the femurAge Ageing19871663733773425483
   PubMed Web of Science ®Google Scholar
• JacobsenSJSargentDJAtkinsonEJO’FallonWMMeltonLJContribution of weather to the seasonality of distal forearm fractures: a population-based study in Rochester, MinnesotaOsteoporos Int19999325425910450415
   PubMed Web of Science ®Google Scholar
• EdwardsBJSongJDunlopDDFinkHACauleyJAFunctional decline after incident wrist fractures – Study of Osteoporotic Fractures: prospective cohort studyBMJ2010341c332420616099
   PubMed Web of Science ®Google Scholar
• PikeCBirnbaumHGSchillerMSharmaHBurgeREdgellETDirect and indirect costs of non-vertebral fracture patients with osteoporosis in the USPharmacoeconomics201028539540920402541
   PubMed Web of Science ®Google Scholar
• HäusslerBGotheHGölDGlaeskeGPientkaLFelsenbergDEpidemiology, treatment and costs of osteoporosis in Germany – the BoneEVA StudyOsteoporos Int2007181778417048064
   PubMed Web of Science ®Google Scholar
• ReidIRRelationships between fat and boneOsteoporos Int200819559560617965817
   PubMed Web of Science ®Google Scholar
• LiuSLiJShengZWuXLiaoERelationship between body composition and age, menopause and its effects on bone mineral density at segmental regions in Central Southern Chinese postmenopausal elderly women with and without osteoporosisArch Gerontol Geriatr2011532192197
   PubMed Web of Science ®Google Scholar
• HsuYHVennersSATerwedowHAFengYNiuTRelation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and womenAm J Clin Nutr200683114615416400063
   PubMed Web of Science ®Google Scholar
• ShanPFWuXPZhangHCaoXZYuanLQLiaoEYAge-related bone mineral density, osteoporosis rate and risk of vertebral fracture in mainland Chinese women with type 2 diabetes mellitusJ Endocrinol Invest201134319019620808073
   PubMed Web of Science ®Google Scholar
• ZhouYLiYZhangDWangJYangHPrevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetesDiabetes Res Clin Pract201090326126920950884
   PubMed Web of Science ®Google Scholar
• HannanMTFelsonDTDawson-HughesBRisk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis StudyJ Bone Miner Res200015471072010780863
   PubMed Web of Science ®Google Scholar
• ShengZXuKOuYRelationship of body composition with prevalence of osteoporosis in central south Chinese postmenopausal womenClin Endocrinol (Oxf)201174331932421114512
   PubMed Web of Science ®Google Scholar
• BlumMHarrisSSMustALeptin, body composition and bone mineral density in premenopausal womenCalcif Tissue Int2003731273214506951
   PubMed Web of Science ®Google Scholar
• MoritaYIwamotoIMizumaNPrecedence of the shift of body-fat distribution over the change in body composition after menopauseJ Obstet Gynaecol Res200632551351616984520
   PubMed Web of Science ®Google Scholar
• KangDHGuoLFGuoTAssociation of body composition with bone mineral density in northern Chinese men by different criteria for obesityJ Endocrinol Invest Epub2014925
   Web of Science ®Google Scholar
• NormanAWBouillonRWhitingSJViethRLipsP13th Workshop consensus for vitamin D nutritional guidelinesJ Steroid Biochem Mol Biol20071033–520420517234402
   PubMed Web of Science ®Google Scholar
• FooLHZhangQZhuKRelationship between vitamin D status, body composition and physical exercise of adolescent girls in BeijingOsteoporos Int200920341742518629568
   PubMed Web of Science ®Google Scholar
• LuLYuZPanAPlasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individualsDiabetes Care20093271278128319366976
   PubMed Web of Science ®Google Scholar
• YanLPrenticeAZhangHWangXStirlingDMGoldenMMVitamin D status and parathyroid hormone concentrations in Chinese women and men from north-east of the People’s Republic of ChinaEur J Clin Nutr2000541687210694775
   PubMed Web of Science ®Google Scholar
• ZhenDLiuLGuanCZhaoNTangXHigh prevalence of vitamin D deficiency among middle-aged and elderly individuals in northwestern China: its relationship to osteoporosis and lifestyle factorsBone2015711625284157
   PubMed Web of Science ®Google Scholar
• WatWZLeungJYTamSKungAWPrevalence and impact of vitamin D insufficiency in southern Chinese adultsAnn Nutr Metab2007511596417356256
   PubMed Web of Science ®Google Scholar
• XiaZZXiaZWuWHigh prevalence of vitamin D insuffi-ciency and deficiency among postmenopausal women in ChinaThe 7th International Conference on Osteoporosis and Bone Metabolism Abstract2014
   Google Scholar
• RoyDKBerryJLPyeSRVitamin D status and bone mass in UK South Asian womenBone200740120020416950669
   PubMed Web of Science ®Google Scholar
• KuchukNOPluijmSMvan SchoorNMLoomanCWSmitJHLipsPRelationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older personsJ Clin Endocrinol Metab20099441244125019158198
   PubMed Web of Science ®Google Scholar
• LiSOuYZhangHVitamin D status and its relationship with body composition, bone mineral density and fracture risk in urban central south Chinese postmenopausal womenAnn Nutr Metab2014641131924642634
   PubMed Web of Science ®Google Scholar
• WooJLeungSSHoSCLamTHJanusEDDietary intake and practices in the Hong Kong Chinese populationJ Epidemiol Community Health1998521063163710023462
   PubMed Web of Science ®Google Scholar
• NelsonMEFiataroneMAMorgantiCMTriceIGreenbergRAEvansWJEffects of high-intensity strength training on multiple risk factors for osteoporotic fractures. A randomized controlled trialJAMA199427224190919147990242
   PubMed Web of Science ®Google Scholar
• ZhangGSPengHLDengMYMah-Jong-related deep vein thrombosisLancet20103759733221420609966
   PubMed Web of Science ®Google Scholar
• NelsonHDNevittMCScottJCStoneKLCummingsSRSmoking, alcohol, and neuromuscular and physical function of older women. Study of Osteoporotic Fractures Research GroupJAMA199427223182518317990216
   PubMed Web of Science ®Google Scholar
• CenterJRBliucDNguyenTVEismanJARisk of subsequent fracture after low-trauma fracture in men and womenJAMA2007297438739417244835
   PubMed Web of Science ®Google Scholar
• IoannidisJPNgMYShamPCMeta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone massJ Bone Miner Res200722217318317228994
   PubMed Web of Science ®Google Scholar
• RichardsJBRivadeneiraFInouyeMBone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association studyLancet200837196231505151218455228
   PubMed Web of Science ®Google Scholar
• StyrkarsdottirUHalldorssonBVGretarsdottirSNew sequence variants associated with bone mineral densityNat Genet2009411151719079262
   PubMed Web of Science ®Google Scholar
• LiuJMZhangMJZhaoLAnalysis of recently identified osteoporosis susceptibility genes in Han Chinese womenJ Clin Endocrinol Metab2010959E112E12020554715
   PubMed Web of Science ®Google Scholar
• LiNWangXJiangYAssociation of GALNT3 gene polymorphisms with bone mineral density in Chinese postmenopausal women: the Peking Vertebral Fracture studyMenopause201421551552124045674
   PubMed Web of Science ®Google Scholar
• CummingsSRNevittMCBrownerWSRisk factors for hip fracture in white women. Study of Osteoporotic Fractures Research GroupN Engl J Med1994332127677737862179
   PubMed Web of Science ®Google Scholar
• NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and TherapyOsteoporosis prevention, diagnosis, and therapyJAMA2001285678579511176917
   PubMed Web of Science ®Google Scholar
• KhoslaSBilezikianJPThe role of estrogens in men and androgens in womenEndocrinol Metab Clin North Am200332119521812699299
   PubMed Web of Science ®Google Scholar
• LevineJPPharmacologic and nonpharmacologic management of osteoporosisClin Cornerstone200681405317591575
   PubMedGoogle Scholar
• WuCHYangYCYaoWJLuFHWuJSChangCJEpidemiological evidence of increased bone mineral density in habitual tea drinkersArch Intern Med200216291001100611996609
   PubMedGoogle Scholar
• KeramatAPatwardhanBLarijaniBThe assessment of osteoporosis risk factors in Iranian women compared with Indian womenBMC Musculoskelet Disord200892818304358
   PubMed Web of Science ®Google Scholar
• Hernández-AvilaMStampferMJRavnikarVACaffeine and other predictors of bone density among pre- and perimenopausal womenEpidemiology1993421281348452901
   PubMed Web of Science ®Google Scholar
• Hamdi KaraIAydinSGemalmazAHabitual tea drinking and bone mineral density in postmenopausal Turkish women: investigation of prevalence of postmenopausal osteoporosis in Turkey (IPPOT Study)Int J Vitam Nutr Res200777638939718622949
   PubMed Web of Science ®Google Scholar
• BerrySDKielDPDonaldsonMGApplication of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis StudyOsteoporos Int2010211536019937426
   PubMed Web of Science ®Google Scholar
• TranHAPetrovskyNPregnancy-associated osteoporosis with hypercalcaemiaIntern Med J2002329–1048148512380703
   PubMed Web of Science ®Google Scholar
• PerisPGuañabensNMonegalAPregnancy associated osteoporosis: the familial effectClin Exp Rheumatol200220569770012412203
   PubMed Web of Science ®Google Scholar
• ErnstEExercise for female osteoporosis. A systematic review of randomised clinical trialsSports Med19982563593689680658
   PubMed Web of Science ®Google Scholar
• BonnerFJSinakiMGraboisMHealth professional’s guide to rehabilitation of the patient with osteoporosisOsteoporos Int200314Suppl 2S1S2212759719
   PubMed Web of Science ®Google Scholar
• GrissoJAKelseyJLStromBLRisk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study GroupN Engl J Med199132419132613312017229
   PubMed Web of Science ®Google Scholar
• Panel on Prevention of Falls in Older Persons, American Geriatrics Society and British Geriatrics SocietySummary of the Updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older personsJ Am Geriatr Soc201159114815721226685
   PubMed Web of Science ®Google Scholar
• Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause SocietyMenopause20101712554 quiz 55–5620061894
   PubMed Web of Science ®Google Scholar
• WolfSLBarnhartHXKutnerNGMcNeelyECooglerCXuTReducing frailty and falls in older persons: an investigation of Tai Chi and computerized balance training. Atlanta FICSIT Group. Frailty and Injuries: Cooperative Studies of Intervention TechniquesJ Am Geriatr Soc19964454894978617895
   PubMed Web of Science ®Google Scholar
• LimMRHuangRCWuAGirardiFPCammisaFPJrEvaluation of the elderly patient with an abnormal gaitJ Am Acad Orthop Surg200715210711717277257
   PubMed Web of Science ®Google Scholar
• BachmeyerCGauthierMHow to prevent glucocorticoid-induced osteoporosisCleve Clin J Med20107711762 author reply 76221086710
   PubMed Web of Science ®Google Scholar
• PereiraRMCarvalhoJFCanalisEGlucocorticoid-induced osteoporosis in rheumatic diseasesClinics (Sao Paulo)201065111197120521243296
   PubMed Web of Science ®Google Scholar
• The Chinese Society of Osteoporosis and Bone Mineral ResearchTreatment guideline of glucocorticoid-induced osteoporosischin j gen pract200608460461 Chinese
   Google Scholar
• Chinese Medical Association of RheumatologyExperts consensus on diagnosis and treatment of glucocorticoid-induced osteoporosisChinese Journal of Rheumatology2013176363368 Chinese
   Google Scholar
• GrossmanJMGordonRRanganathVKAmerican College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosisArthritis Care Res (Hoboken)201062111515152620662044
   PubMed Web of Science ®Google Scholar
• RouxCRajzbaumGMorelGManagement of glucocorticoid-induced osteoporosis: lessons for clinical practiceJoint Bone Spine201178Suppl 2S222S22622153676
   PubMed Web of Science ®Google Scholar
• VenuturupalliSRSacksWReview of new guidelines for the management of glucocorticoid induced osteoporosisCurr Osteoporos Rep201311435736424114241
   PubMed Web of Science ®Google Scholar
• Glucocorticoid induced osteoporosis treatment guidelinesChinese Journal of General Practitioners200608460461
   Google Scholar
• SuzukiYNawataHSoenSFujiwaraSNakayamaHGuidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 updateJ Bone Miner Metab201432433735024818875
   PubMed Web of Science ®Google Scholar
• ChopinFHoppéEMorelGBiverEBorgSThomasTSelecting the optimal treatment for glucocorticoid-induced osteoporosisJoint Bone Spine201178Suppl 2S218S22122153675
   PubMed Web of Science ®Google Scholar
• BriotKCortetBRouxCFardetLAbitbolV2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosisJoint Bone Spine201481649350125455041
   PubMed Web of Science ®Google Scholar
• ZhaoYHWangMWProgress of experimental research on prevention and treatment of osteoporosis by traditional Chinese medicineZhongguo Zhong Xi Yi Jie He Za Zhi2003231294394514714372
   PubMedGoogle Scholar
• DuGCaoCReview on experiment of traditional Chinese medicine treating to osteoporosisZhongguo Zhong Yao Za Zhi201136440140421598528
   PubMedGoogle Scholar
• LagariVSLevisSPhytoestrogens in the prevention of postmenopausal bone lossJ Clin Densitom201316444544924090647
   PubMed Web of Science ®Google Scholar
• GuoAJChoiRCCheungAWBaicalin, a flavone, induces the differentiation of cultured osteoblasts: an action via the Wnt/beta-catenin signaling pathwayJ Biol Chem201128632278822789321652696
   PubMed Web of Science ®Google Scholar
• LiCRZhangGWNiuYBPanYLZhaiYKMeiQBAntiosteopo-rosis effect of radix scutellariae extract on density and microstructure of long bones in tail-suspended sprague-dawley ratsEvid Based Complement Alternat Med2013201375370324223617
   PubMed Web of Science ®Google Scholar
• LiuMXiaoGGRongPSemen Astragali Complanati- and Rhizoma Cibotii-enhanced bone formation in osteoporosis ratsBMC Complement Altern Med20131314123782721
   PubMed Web of Science ®Google Scholar
• ZhuHMQinLGarneroPThe first multicenter and random-ized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosisOsteoporos Int20122341317132721505910
   PubMed Web of Science ®Google Scholar
• WattsNBDiabDLLong-term use of bisphosphonates in osteoporosisJ Clin Endocrinol Metab20109541555156520173017
   PubMed Web of Science ®Google Scholar
• SchnitzerTBoneHGCrepaldiGTherapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study GroupAging (Milano)200012111210746426
   PubMedGoogle Scholar
• BoneHGHoskingDDevogelaerJPAlendronate Phase III Osteoporosis Treatment Study GroupTen years’ experience with alendronate for osteoporosis in postmenopausal womenN Engl J Med2004350121189119915028823
   PubMed Web of Science ®Google Scholar
• HarringtonJTSte-MarieLGBrandiMLRisedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosisCalcif Tissue Int200474212913514648009
   PubMed Web of Science ®Google Scholar
• WhitakerMGuoJKehoeTBensonGBisphosphonates for osteoporosis – where do we go from here?N Engl J Med2012366222048205122571168
   PubMed Web of Science ®Google Scholar
• DelmasPDMcClungMRZanchettaJREfficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosisBone2008421364217920005
   PubMed Web of Science ®Google Scholar
• BlackDMDelmasPDEastellRHORIZON Pivotal Fracture TrialOnce-yearly zolendronic acid for treatment of postmenopausal osteoporosisN Engl J Med2007356181809182217476007
   PubMed Web of Science ®Google Scholar
• ChesnutIII CHSkagAChristiansenCOral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE)Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosisJ Bone Miner Res20041981241124915231010
   PubMed Web of Science ®Google Scholar
• ChesnutCH3rdSilvermanSAndrianoKA randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study GroupAm J Med2000109426727610996576
   PubMed Web of Science ®Google Scholar
• CauleyJARobbinsJChenZWomen’s Health Initiative InvestigatorsEffects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trialJAMA2003290131729173814519707
   PubMed Web of Science ®Google Scholar
• SimonJAWehrenLEAscott-EvansBHOmizoMKSilfenSLLom-bardiASkeletal consequences of hormone therapy discontinuance: a systematic reviewObstet Gynecol Surv200661211512416433935
   PubMed Web of Science ®Google Scholar
• DelmasPDEnsrudKEAdachiJDMulitple Outcomes of Ral-oxifene Evaluation InvestigatorsEfficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trialJ Clin Endocrinol Metab20028783609361712161484
   PubMed Web of Science ®Google Scholar
• EttingerBBlackDMMitlakBHReduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) InvestigatorsJAMA1999282763764510517716
   PubMed Web of Science ®Google Scholar
• NelsonHDSmithMEGriffinJCFuRUse of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task ForceAnn Intern Med2013158860461423588749
   PubMed Web of Science ®Google Scholar
• CummingsSRSan MartinJMcClungMRFREEDOM TrialDenosumab for prevention of fractures in postmenopausal women with osteoporosisN Engl J Med2009361875676519671655
   PubMed Web of Science ®Google Scholar
• DelmasPDClinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseasesJ Clin Densitom200811232533818375161
   PubMed Web of Science ®Google Scholar
• WattsNBLewieckiEMMillerPDBaimSNational Osteoporosis Foundation 2008 Clinician’s Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologistJ Clin Densitom200811447347718562228
   PubMed Web of Science ®Google Scholar
• NeerRMArnaudCDZanchettaJREffect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosisN Engl J Med2001344191434144111346808
   PubMed Web of Science ®Google Scholar
• BaronRHesseEUpdate on bone anabolics in osteoporosis treatment: rationale, current status, and perspectivesJ Clin Endocrinol Metab201297231132522238383
   PubMed Web of Science ®Google Scholar
• MeunierPJRouxCSeemanEThe effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosisN Engl J Med2004350545946814749454
   PubMed Web of Science ®Google Scholar
• ReginsterJYSeemanEDe VernejoulMCStrontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) studyJ Clin Endocrinol Metab20059052816282215728210
   PubMed Web of Science ®Google Scholar
• PinkertonJVDalkinACCombination therapy for treatment of osteoporosis: a reviewAm J Obstet Gynecol2007197655956518060937
   PubMed Web of Science ®Google Scholar
• WuXPangLLeiWInhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodelingCell Stem Cell20107557158021040899
   PubMed Web of Science ®Google Scholar
• FinkelsteinJSWylandJJLeeHNeerRMEffects of teriparatide, alendronate, or both in women with postmenopausal osteoporosisJ Clin Endocrinol Metab20109541838184520164296
   PubMed Web of Science ®Google Scholar
• BlackDMGreenspanSLEnsrudKEPaTH Study InvestigatorsThe effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosisN Engl J Med2003349131207121514500804
   PubMed Web of Science ®Google Scholar
• MuschitzCKocijanRFahrleitner-PammerALungSReschHAntiresorptives overlapping ongoing teriparatide treatment result in additional increases in bone mineral densityJ Bone Miner Res201328119620522836585
   PubMed Web of Science ®Google Scholar
• BucklandJOsteoporosis: Teriparatide and denosumab: two drugs are better than one!Nat Rev Rheumatol20139738323712125
   PubMedGoogle Scholar
• TsaiJNUihleinAVLeeHTeriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trialLancet20133829886505623683600
   PubMed Web of Science ®Google Scholar
• MillerPDChinesAAChristiansenCEffects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled studyJ Bone Miner Res200823452553518072873
   PubMed Web of Science ®Google Scholar
• ClarkeBLAnti-sclerostin antibodies: utility in treatment of osteoporosisMaturitas201478319920424842796
   PubMed Web of Science ®Google Scholar
• BaronRKneisselMWNT signaling in bone homeostasis and disease: from human mutations to treatmentsNat Med201319217919223389618
   PubMed Web of Science ®Google Scholar
• GuanMYaoWLiuRDirecting mesenchymal stem cells to bone to augment bone formation and increase bone massNat Med201218345646222306732
   PubMed Web of Science ®Google Scholar